Echo Therapeutics, Inc. Future Amortization Expense, Year Five (Deprecated 2012-01-31)
Echo Therapeutics, Inc. reported Future Amortization Expense, Year Five (Deprecated 2012-01-31) of $1.75 million for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:FutureAmortizationExpenseYearFive · last filed 2013-05-10
- Echo Therapeutics, Inc. future amortization expense, year five (deprecated 2012-01-31) for the quarter ending 2013-03-31 was $1.75M.
| Period end | Future Amortization Expense, Year Five (Deprecated 2012-01-31) 3 month |
|---|---|
| 2013-03-31 | $1.75M 10-Q · filed 2013-05-10 |